Skip to content
Governance Register

← US public companies

Ohr Pharmaceutical Inc

SEC CIK 1173281 · OHRP · last insider filing 2023-09-20

Directors (from insider filings)

NameCapacity as filedFilings
Stephan Dietrich A Director · President and CEO filed 2019 - 2023
Goldstein DOV A MD Director filed 2019 - 2022
Prendergast Franklyn G Director filed 2019 - 2022
Richman Eric I Director filed 2019 - 2022
Ende Eric J Director filed 2022 - 2022
Mcdougall Gerald J Director filed 2021 - 2022
Miralles Gines Diego Director filed 2019 - 2020
Hirschman Orin Director filed 2013 - 2017
Riedhammer Thomas M Director filed 2013 - 2017
Almenoff June Sherie Director filed 2013 - 2017
Ferguson Michael Director filed 2017 - 2017
Slakter Jason Scott Director · Chief Executive Officer filed 2015 - 2017
Greenstein IRA A Director · Chairman of the Board filed 2013 - 2016
Taraporewala Irach B. Director · Chief Executive Officer filed 2013 - 2015

Officers (from insider filings)

NameTitle as filedFilings
Branning Todd P. Chief Financial Officer filed 2022 - 2023
Mann William Roland Chief Operating Officer filed 2020 - 2022
Rojas-Caro Sandra Chief Medical Officer filed 2021 - 2022
Motesharei Kianoush See Remarks filed 2021 - 2021
Backenroth Samuel Chief Financial Officer filed 2013 - 2020
Bradshaw Curt Chief Scientific Officer filed 2020 - 2020
Ingerman Avner Chief Clinical Officer filed 2015 - 2015

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.